森松国际(02155)发布公告,宣布公司与全资附属公司森松(中国)投资、上海森松制药设备工程有限公司及投资方于2025年7月7日签署交易文件。根据协议,投资方同意以3.3亿元认购森松制药1295万元的新增注册资本,完成后森松制药的注册资本将由8631万元增加至9926万元。公告指出,当前公司以直接和间接方式拥有森松制药约85.09%的股权。假设投资方完成认购事项,公司的股权将减少至约73.99%,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.